Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Edoardo Olivari
Observed name:
E. Olivari
Institution:
Ospedale Papa Giovanni XXIII
Observed institutions:
University of Milan,
Ospedale Papa Giovanni XXIII
ORCID:
0009-0007-2717-4309
Observed ORCID:
0009-0007-2717-4309
OpenAlex ID:
A5093393566
Interim-PET predicts progression-free survival in stage IV Hodgkin lymphoma treated with upfront brentuximab vedotin-AVD
2025
·
Chiara Rusconi
, Angelica Barone
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
3
CMV Reactivations During and after Letermovir Prophylaxis In Allogeneic Hematopoietic Stem Cell Transplantation: a Single-Center Experience.
2025
·
Edoardo Olivari
, Chiara Pavoni
, et al.
·
Mediterranean Journal of Hematology and Infectious Diseases
·
2
PDF
Addition of daratumumab to first-line therapy of newly diagnosed multiple myeloma in patients eligible for autologous stem cell transplantation: a single-center real-life experience
2025
·
Edoardo Olivari
, Laura Paris
, et al.
·
Mediterranean Journal of Hematology and Infectious Diseases
·
1
PDF
Evaluation of Couples at Risk for Hemoglobin Disorders in Italy: The Results of an 18-Month Retrospective Observational Single-Center Study
2023
·
Alfredo Marchetti
, Elisa Sambruna
, et al.
·
Blood
·
1
PDF
Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real‐life study from European Myeloma Network ( EMN ) Italy
2026
·
Gregorio Barilà
, Angela Grassi
, et al.
·
British Journal of Haematology
PDF
The treatment of patients primary refractory or with sub-optimal response to d-VTD induction: An italian real-life Study
2025
·
Gregorio Barila
, Francesco Tarantini
, et al.
·
Blood
PDF
Show more works
View as search
Works count:
7
Citation count:
7
H-index:
2
I10-index:
Year
Topic
Type